3Vote!
Joseph Kim, MD, MPH (Free subscription) | 20/11/2009
OK, this is not technically toothpaste. However, it sure looks like it. This is an image of a man's elbow and it's from the New England Journal of Medicine (NEJM). A 77-yr-old man renal-cell carcinoma (kidney cancer) presented with painful swelling of his elbow. This white chalky substance was a result of an acute flare of previously asymptomatic, chronic tophaceous gout. Hence, this image receives...
3Vote!
Gold-Plated Witch on Wheels (Free subscription) | 12/11/2009
Chuck has posted several links to examples of the great care one receives from socialized medicine: Cancer survivor confronts the health secretary on 62-day wait The current target of 62 days from urgent referral by a doctor to starting treatment has still not been met in Scotland, despite that originally being the target figure for 2005. Girl, 3, has heart operation cancelled three times because of...
3Vote!
Back on the (no)gravy train... (Free subscription) | 12/11/2009
So there i was lying in bed, not sleeping and thinking about how shit it was that everything reminded me of O, when whaddyaknow my phone rings. My really drunk friend informing me that 'kidney cancer' can now be added to the enormous list of health problems she is facing. So i went for a 3am run. It's so quiet here at night. I ran and ran and ran and didnt see anyone. It was quite nice actually, peaceful...
3Vote!
Pinoy Healthcare (Free subscription) | 11/11/2009
Colon cancer is cancer of the large intestine (colon), the lower part of your digestive system. Colon cancer is the second most common cancer in the USA with equal distribution between men and women. Colon tumors usually affect people over the age of 40, with the majority of people who are diagnosed with the condition [...] Related Posts Bone Cancer: Causes, Symptoms, Diagnosis, Treatment and Prognosis...
3Vote!
Pinoy Healthcare (Free subscription) | 11/11/2009
Determining the ****** cancer stages is important since it enables the patient and doctor to identify the treatment necessary for one’s condition. Also, it is essential in assessing the risk of the given condition and what lifestyle changes the patient can do to improve their health.Identifying A ****** Cancer’s StageWhen talking about ****** cancer stages, [...] Related Posts Breast Cancer...
3Vote!
Pinoy Healthcare (Free subscription) | 10/11/2009
Do you find yourself searching for facts about ovarian cancer?Well here are a couple quick facts for you.The ovaries belong to the female reproductive system and produce eggs each month during the reproductive years of a woman. You will find that they are located on either side of the woman’s lower abdomen. Ovarian cancer occurs [...] Related Posts Ovarian Cancer - Don’t Ignore the Warning...
3Vote!
Today With President Barack Obama (Free subscription) | 10/11/2009
Regina Holliday's husband Fred died at 39 of kidney cancer and in pain. Much of that pain was physical and was brought on by our horrible healthcare system. She's going to continue to paint to speak for others' healthcare nightmares. The more I see stories like this, the more I think we need a single payer system that has no profit motive. Listen to her story here .
3Vote!
North Country Gazette (Free subscription) | 10/11/2009
GLENS FALLS—A Glens Falls woman has admitted defrauding donors who contributed thousands of dollars to her for medical expenses related to her fictitious battle against kidney cancer. Melanie Brown, 30, of First St., pleaded guilty Monday in Warren County Court to an 11-count indictment of nine felonies and two misdemeanors. Brown will avoid incarceration for the moment [...]
3Vote!
Xconomy (Free subscription) | 28/10/2009
Europe’s drug regulators were not kind to a couple of Massachusetts biotech firms this week, but other New England life sciences companies had happier news to report. —European drug regulators turned down Lexington, MA-based Antigenics’ bid for approval to market vitespen (Oncophage), a “cancer vaccine” for patients with kidney cancer. Shares of Antigenics (NASDAQ: AGEN)...
3Vote!
Head Nurse (Free subscription) | 27/10/2009
And it was really nice. For a whole day and a half, I had nothing to do but eat good food, yammer at interesting people, and listen to Neko Case and Fountains of Wayne on the car stereo. Meanwhile, the family of a patient I had last week was discussing whether or not to turn off the vent and make Grandma a DNR. Grandma is not going to wake up, sadly; she had one of those intracerebral hemorrhages best...
3Vote!
Medindia Health News (Free subscription) | 22/10/2009
The US FDA has given its nod for Votrient (pazopanib) for treatment of advanced kidney cancer. The drug is manufacture b
3Vote!
The Inquisitr (Free subscription) | 22/10/2009
The U.S. Food and Drug Administration approved a new drug for the treatment of kidney cancer this week. The drug, Votrient, is an oral medication that interferes with the growth of new blood vessels that are needed for solid tumor growth and survival. It is made by London drug maker GlaxoSmithKline. Votrient is intended for people with [...]
3Vote!
Fiercebiotech (Free subscription) | 21/10/2009
Antigenics (AGEN) has a fresh round of sour news to report this morning, announcing that European regulators will soon formally reject its kidney cancer vaccine Oncophage. The UK biotech said that it was told of the decision verbally. And discouraged investors quickly bailed on the company's stock, which plunged 43 percent. Antigenics had held out hopes for Oncophage despite two pivotal trial failures...
3Vote!
iStockAnalyst.com (Free subscription) | 21/10/2009
On 6/1/09, Antigenics (NASDAQ: AGEN) announced results of an interim analysis from the Company’s ongoing global patient survival registry, which showed that patients with kidney cancer at intermediate risk of disease recurrence demonstrated an approximately 46% lower risk of death when treated with Oncophage (vitespen) cancer vaccine compared with observation ( [More...]
3Vote!
Health - The Post Chronicle (Free subscription) | 20/10/2009
The FDA said the newly approved drug, Votrient (pazopanib), interferes with angiogenesis --...
Videos